15th April 2021

MarketsandMarkets qPCR and dPCR Virtual Conference [ Time Zone - Central European Time]

12+
Speakers
100+
Attendees

Advancing qPCR and dPCR technological developments and its applications in oncology and infectious disease diagnostics

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

MarketsandMarkets are proud to host its inaugural “qPCR and dPCR Virtual Conference” which will be held on 15th - 16th April 2021. The conference will focus on the latest developments in digital and real time PCR and also, its application in cancer diagnosis and infectious disease diagnostics.

WHAT TO EXPECT
Key Highlights
  • New developments in qPCR and dPCR
  • Introduction, Benefits, Future Development of dPCR and qPCR
  • Applications of qPCR and dPCR in cancer diagnosis and infectious diseases diagnostics
  • Data Analysis and Standardization
  • Latest technologies used in qPCR and dPCR and how it helps in clinical diagnostics
     
Who should attend?

From Universities and Pharma/Therapeutic Companies

Professors, Lecturers, Scientists, Researchers, Lab Heads, Managers, Directors working in-

  • qPCR
  • Digital PCR
  • NGS
  • Assay Development
  • Infectious Diseases
  • Microbiology
  • Oncology
  • Bioinformatics
  • Data Analysis
  • Genomics
  • Single Cell Analysis

 

CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
David Zarling

David Zarling

CEO
Colby Pharmaceuticals, USA

David Zarling

CEO
Colby Pharmaceuticals, USA
Valerie Taly

Valerie Taly

Research Director
CNRS, INSERM, France

Valerie Taly

Research Director
CNRS, INSERM, France
Andreas Weinhaeusel

Andreas Weinhaeusel

Thematic Coordinator, Molecular Diagnostics
AIT Austrian Institute of Technology, Austria

Andreas Weinhaeusel

Thematic Coordinator, Molecular Diagnostics
AIT Austrian Institute of Technology, Austria
Wim Trypsteen

Wim Trypsteen

Faculty of Medicine and Health Sciences
Ghent University, Europe

Wim Trypsteen

Faculty of Medicine and Health Sciences
Ghent University, Europe
Michael Powell

Michael Powell

Chief Scientific Officer
DiaCarta, USA

Michael Powell

Chief Scientific Officer
DiaCarta, USA
Preeti Panda

Preeti Panda

Head Business Development
INVITEK Molecular, Germany

Preeti Panda

Head Business Development
INVITEK Molecular, Germany
Piotr Garstecki

Piotr Garstecki

Co-Founder
Scope Fluidics, Poland

Piotr Garstecki

Co-Founder
Scope Fluidics, Poland
Tim Julian

Tim Julian

Eawag, Switzerland
Group Leader in the Department of Environmental Microbiology

Tim Julian

Eawag, Switzerland
Group Leader in the Department of Environmental Microbiology
SPONSORS
Speaking Partner
example-image

Scope Fluids

example-image

Invitek

example-image

Stilla Technologies

PARTNERS
Media Partners
example-image

PharmaVOICE

example-image

PharmaTutor

example-image

Pharma Journalist

PAST EVENT GALLERY